Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| Splice region | donor +280 | deep intronic (+280 nt into the intron) |
|---|---|---|
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 0.5 | GERP 0.17, phastCons 0.41 |
| Overall | ||
| CADD | 9.511 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 1.61% | 62 |
| Admixed American | 1.21% | 83 |
| Middle Eastern | 0.68% | 147 |
| Ashkenazi Jewishnot grpmax-eligible | 0.577% | 173 |
| Remaining individualsnot grpmax-eligible | 0.523% | 191 |
| African / African-American | 0.308% | 324 |
| South Asian | 0.228% | 438 |
| Finnishnot grpmax-eligible | 0.227% | 441 |
| East Asian | 0.0193% | 5,180 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- BRCA1
- Coding
- c.441+280G>A
- MANE Select
- NM_007294
- dbSNP
- rs8176137
- Type
- single nucleotide variant
- Location
- chr17:43103842 (GRCh38)
- Gene constraint
- LOEUF 0.885 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 41.99 · 33 PDB
Disease context
breast-ovarian cancer, familial, susceptibility to, 1 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hereditary breast and/or ovarian cancer syndrome (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult, Elderly
Similar variants
- BRCA1 c.134+3A>T Likely pathogenic ★★★ same condition
- BRCA1 c.135-1G>T Pathogenic ★★★ same condition
- BRCA1 c.212+1G>A Pathogenic ★★★ same condition
- BRCA1 c.212+1G>T Pathogenic ★★★ same condition
- BRCA1 c.212+3A>G Pathogenic ★★★ same condition
- BRCA1 c.213-12A>G Pathogenic ★★★ same condition
- BRCA1 c.213-15A>G Likely pathogenic ★★★ same condition
- BRCA1 c.302-1G>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/brca1-c-441-plus-280g-a (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown